Capital Royalty Group (CRG)

Capital Royalty Group (CRG)

Capital Royalty Group (CRG) is a premier healthcare investment firm that has managed over $3 billion of institutional capital since inception and its senior investment professionals have led over 50 investments.

Capital Royalty Group is a global healthcare investor that has operated across the globe since 2003.

Investing capital debt and equity structures in collaborative partnerships to focus on minimized dilution and strong value-added support for companies has been a consistent role for Capital Royalty Group. The firm is interested in companies such as Harmony Biosciences, HNI Healthcare, Earlens Corporation, EndoGastric Solutions, Synergy Pharmaceuticals, Stonebridge Biopharma, and Silk Road Medical.

Timeline

Funded Companies

Company
Description
Website
Industry
Location

EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).

Silk Road Medical is a Sunnyvale, California-based healthcare company.

Intrinsic Therapeutics is a Woburn, Massachusetts-based healthcare company.

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.